3,4-methylenedioxyamphetamine has been researched along with Liver Diseases in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Liver Diseases: Pathological processes of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tillmann, HL | 1 |
| van Pelt, FN | 1 |
| Martz, W | 1 |
| Luecke, T | 1 |
| Welp, H | 1 |
| Dörries, F | 1 |
| Veuskens, A | 1 |
| Fischer, M | 1 |
| Manns, MP | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Liver Diseases
| Article | Year |
|---|---|
Accidental intoxication with methylene dianiline p,p'-diaminodiphenylmethane: acute liver damage after presumed ecstasy consumption.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Aniline Compounds; Carcinogens; Chemical and Drug | 1997 |